[Molecular Diagnosis of Hand Eczema]

Overview

Journal Dermatologie (Heidelb)

Specialty Dermatology

Date 2023 Jun 5

PMID 37272967

Authors

Kristin Technau-Hafsi

Natalie Garzorz-Stark

Kilian Eyerich

Affiliations

Soon will be listed here.

Abstract

Background: Because hand eczema is a diagnostic challenge even for experienced dermatologists, a correct diagnosis is essential to ensure success of specific therapies.

Objectives: Prerequisites for successful molecular diagnostics in general and in hand eczema in particular are discussed.

Materials And Methods: Basic research and opinion statement on new developments in molecular diagnostics are considered with a special focus on hand eczema.

Results: The first molecular classifier to distinguish psoriasis from (hand) eczema signature has been introduced as CE-marked in vitro diagnostics (CE-IVD); many more biomarkers associated with diagnostics, theranostics, or natural course of the disease are currently being investigated.

Conclusions: Diagnosis of hand eczema will be supported by molecular diagnostics in the near future; we are at the beginning of the molecular era in dermatology.

Citing Articles

Chronic Hand Eczema.

Weisshaar E Am J Clin Dermatol. 2024; 25(6):909-926.

PMID: 39300011 PMC: 11511713. DOI: 10.1007/s40257-024-00890-z.

References

Ziehfreund S, Tizek L, Hangel N, Fritzsche M, Weidinger S, Smith C . Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts. J Eur Acad Dermatol Venereol. 2022; 36(9):1467-1476. DOI: 10.1111/jdv.18178. View

Kolesnik M, Franke I, Lux A, Quist S, Gollnick H . Eczema in Psoriatico: An Important Differential Diagnosis Between Chronic Allergic Contact Dermatitis and Psoriasis in Palmoplantar Localization. Acta Derm Venereol. 2017; 98(1):50-58. DOI: 10.2340/00015555-2779. View

Cesinaro A, Nannini N, Migaldi M, Pepe P, Maiorana A . Psoriasis vs allergic contact dermatitis in palms and soles: a quantitative histologic and immunohistochemical study. APMIS. 2009; 117(8):629-34. DOI: 10.1111/j.1600-0463.2009.02513.x. View

Diepgen T, Elsner P, Schliemann S, Fartasch M, Kollner A, Skudlik C . Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges. 2009; 7 Suppl 3:S1-16. DOI: 10.1111/j.1610-0387.2009.07061.x. View

Boonstra M, Christoffers W, Coenraads P, Schuttelaar M . Patch test results of hand eczema patients: relation to clinical types. J Eur Acad Dermatol Venereol. 2014; 29(5):940-7. DOI: 10.1111/jdv.12735. View

Vigneshkarthik N, Ganguly S, Kuruvila S . Patch Test as a Diagnostic Tool in Hand Eczema. J Clin Diagn Res. 2017; 10(11):WC04-WC07. PMC: 5198439. DOI: 10.7860/JCDR/2016/23994.8884. View

Eyerich K, Eyerich S . Immune response patterns in non-communicable inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2017; 32(5):692-703. PMC: 5947562. DOI: 10.1111/jdv.14673. View

Blauvelt A, de Bruin-Weller M, Gooderham M, Cather J, Weisman J, Pariser D . Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017; 389(10086):2287-2303. DOI: 10.1016/S0140-6736(17)31191-1. View

Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour J . Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2020; 184(3):437-449. PMC: 7986411. DOI: 10.1111/bjd.19574. View

10.

Oosterhaven J, Voorberg A, Romeijn G, de Bruin-Weller M, Schuttelaar M . Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. J Dermatol. 2019; 46(8):680-685. PMC: 6771665. DOI: 10.1111/1346-8138.14982. View

11.

Umezawa Y, Ito K, Nakagawa H . Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab. Eur J Dermatol. 2013; 23(6):910-1. DOI: 10.1684/ejd.2013.2197. View

12.

Sladden M, Sladden C, Gulliver W . Secukinumab-Induced Psoriasiform Eruption. JAMA Dermatol. 2017; 153(11):1194-1195. DOI: 10.1001/jamadermatol.2017.2826. View

13.

Broderick C, Ziehfreund S, van Bart K, Arents B, Eyerich K, Weidinger S . Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review. Allergy. 2022; 78(1):84-120. PMC: 10107168. DOI: 10.1111/all.15578. View

14.

Schiattarella M, Patruno C, Balato N, Canta L, Caiazzo G, Lembo S . Chronic hand eczema: is IL-36α helpful in diagnosis and classification?. G Ital Dermatol Venereol. 2016; 152(6):578-585. DOI: 10.23736/S0392-0488.16.05312-8. View

15.

Buhl A, Wenzel J . Interleukin-36 in Infectious and Inflammatory Skin Diseases. Front Immunol. 2019; 10:1162. PMC: 6545975. DOI: 10.3389/fimmu.2019.01162. View

16.

DErme A, Wilsmann-Theis D, Wagenpfeil J, Holzel M, Ferring-Schmitt S, Sternberg S . IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol. 2014; 135(4):1025-1032. DOI: 10.1038/jid.2014.532. View

17.

Berekmeri A, Latzko A, Alase A, Macleod T, Ainscough J, Laws P . Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema. J Allergy Clin Immunol. 2018; 142(3):988-991.e4. PMC: 6127028. DOI: 10.1016/j.jaci.2018.04.031. View

18.

Chan T, Sanyal R, Pavel A, Glickman J, Zheng X, Xu H . Atopic dermatitis in Chinese patients shows T2/T17 skewing with psoriasiform features. J Allergy Clin Immunol. 2018; 142(3):1013-1017. DOI: 10.1016/j.jaci.2018.06.016. View

19.

Wenzel J, Peters B, Zahn S, Birth M, Hofmann K, Kusters D . Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol. 2007; 128(1):67-78. DOI: 10.1038/sj.jid.5700945. View

20.

Eyerich S, Onken A, Weidinger S, Franke A, Nasorri F, Pennino D . Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med. 2011; 365(3):231-8. DOI: 10.1056/NEJMoa1104200. View